Evidence map›Paper›PMID 39474520›Full record

ArticleChemical & biomedical imaging2024

Enhancing Open-World Bacterial Raman Spectra Identification by Feature Regularization for Improved Resilience against Unknown Classes.

Yaroslav Balytskyi, Nataliia Kalashnyk, Inna Hubenko, Alina Balytska, Kelly McNear

Abstract read
In one paragraph

Article in Chemical & biomedical imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yaroslav BalytskyiDepartment of Physics and Astronomy, Wayne State University, Detroit, Michigan 48201, United States.ORCID https://orcid.org/0000-0002-7582-6232
Nataliia KalashnykNational University of Civil Protection of Ukraine, Cherkasy 18034, Ukraine.
Inna HubenkoCherkasy Medical Academy, Cherkasy 18000, Ukraine.ORCID https://orcid.org/0000-0002-3798-6489
Alina BalytskaCherkasy Medical Academy, Cherkasy 18000, Ukraine.
Kelly McNearUCCS BioFrontiers Center, University of Colorado, Colorado Springs, Colorado 80918, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The combination of deep learning techniques and Raman spectroscopy shows great potential offering precise and prompt identification of pathogenic bacteria in clinical settings. However, the traditional closed-set classification approaches assume that all test samples belong to one of the known pathogens, and their applicability is limited since the clinical environment is inherently unpredictable and dynamic, unknown, or emerging pathogens may not be included in the available catalogs. We demonstrate that the current state-of-the-art neural networks identifying pathogens through Raman spectra are vulnerable to unknown inputs, resulting in an uncontrollable false positive rate. To address this issue, first we developed an ensemble of ResNet architectures combined with the attention mechanism that achieves a 30-isolate accuracy of 87.8 ± 0.1%. Second, through the integration of feature regularization by the Objectosphere loss function, our model both achieves high accuracy in identifying known pathogens from the catalog and effectively separates unknown samples drastically reducing the false positive rate. Finally, the proposed feature regularization method during training significantly enhances the performance of out-of-distribution detectors during the inference phase improving the reliability of the detection of unknown classes. Our algorithm for Raman spectroscopy empowers the identification of previously unknown, uncataloged, and emerging pathogens ensuring adaptability to future pathogens that may surface. Moreover, it can be extended to enhance open-set medical image classification, bolstering its reliability in dynamic operational settings.

Identifiers

PMID39474520
PMCPMC11503672

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.